Diagnosis of Fabry Disease via Analysis of Family History
- 3 January 2008
- journal article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 17 (1), 79-83
- https://doi.org/10.1007/s10897-007-9128-x
Abstract
Fabry disease is an X-linked lysosomal storage condition caused by a deficiency of α-galactosidase A. In order to determine the average number of family members who are diagnosed with Fabry disease following the diagnosis of a proband, four lysosomal storage disease centers across the United States reviewed the completed pedigrees of their Fabry disease patients. In addition, data from three Fabry disease families from other centers were submitted by patients directly. The pedigree review found 74 probands (54 males and 20 females) who had 357 diagnosed family members, of which 223 were female (60.5%) and 146 were male (39.5%). Analysis found that, on average, there were five family members diagnosed with Fabry disease for every proband. Now that enzyme replacement therapy (ERT) is available for the treatment of Fabry disease, this finding emphasizes the need for all health care professionals to ensure a detailed pedigree has been constructed for each patient affected by Fabry disease and to encourage testing and evaluation of all at-risk family members.This publication has 13 references indexed in Scilit:
- Fabry disease: Guidelines for the evaluation and management of multi-organ system involvementGenetics in Medicine, 2006
- Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic diseaseGenetics in Medicine, 2006
- Natural history of Fabry disease in females in the Fabry Outcome SurveyJournal of Medical Genetics, 2005
- The Relationship of Vascular Glycolipid Storage to Clinical Manifestations of Fabry DiseaseMedicine, 2005
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyEuropean Journal of Clinical Investigation, 2004
- Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement TherapyAnnals of Internal Medicine, 2003
- Fabry Disease in Genetic Counseling Practice: Recommendations of the National Society of Genetic CounselorsJournal of Genetic Counseling, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Anderson–Fabry disease: Clinical manifestations of disease in female heterozygotesJournal of Inherited Metabolic Disease, 2001
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseThe New England Journal of Medicine, 2001